A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer

Prostate cancer (PCa) is one of the most common malignancies in male. We aim to establish a novel gene signature for immune infiltration and outcome (biochemical recurrence (BCR) and overall survival (OS)) of patients with prostate cancer (PCa) to augment Gleason patterns for evaluating prognosis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Ning, Tang, Hong, Mi, Yuanyuan, Zhu, Yao, Wan, Fangning, Ye, Dingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458664/
https://www.ncbi.nlm.nih.gov/pubmed/32923125
http://dx.doi.org/10.1080/2162402X.2020.1762473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458664/
https://www.ncbi.nlm.nih.gov/pubmed/32923125
http://dx.doi.org/10.1080/2162402X.2020.1762473

Ejemplares similares